Open AccessImmunotherapy combinations and chemotherapy sparing schemes in first line non-small cell lung cancer
Author(s) -
María Sereno,
Oliver Higuera,
Pablo Castellanos,
Sandra Falagan,
Xabier Mielgo-Rubio,
Juan Carlos Trujillo-Reyes,
Felipe Couñago
Publication year - 2021
Publication title -
world journal of clinical oncology
Language(s) - English
Resource type - Journals
ISSN - 2218-4333
DOI - 10.5306/wjco.v12.i12.1182
Subject(s) - medicine , tolerability , chemotherapy , lung cancer , immunotherapy , oncology , atezolizumab , cancer , pembrolizumab , adverse effect